Avandia Settlements Reported
Today it was reported that GSK has settled more than 700 Avandia cases for a sum reported to be approximately 60 million dollars. These are the first reported settlements involving the drug and represent a small fraction of the total claims believed to be pending. The average settlement would appear to be around 90-95 thousand dollars per case.
The settlements come as Glaxo is set to face its first Avandia trial in state court in Philadelphia in July. More cases my be filed in the coming days.